Fosamprenavir Calcium/Sodium Alginate

福沙那韦钙/海藻酸钠

Report date: 2026/03/26 20:00:17

Base Information

Drug NameFosamprenavir Calcium/Sodium Alginate
Drug Alias NameFosamprenavir-Sodium AlginateOral Fosamprenavir Sodium AlginateFOS-SANZYM-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Fosamprenavir CalciumSodium Alginate
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesN-Zyme Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN-Zyme Biomedical IncThe Medical College Of Wisconsin Nonprofit
Inactive CompaniesN/A
Active IndicationsGastroesophageal Reflux
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A